Analytical Data
-
Gene name
PF14_0076
- Application
-
Alternative Names
Aspartic hemoglobinase IPfAPG
-
Species
Plasmodium falciparum
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7KQM4
-
Expression Region
125-452aa
-
Molecular Weight
52.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PF14_0076 is a recombinant protein derived from the Plasmodium falciparum, the parasite responsible for the most severe form of malaria. This protein has garnered significant interest due to its potential role in the parasite's life cycle and interaction with the host immune system. Research indicates that PF14_0076 may be involved in critical processes such as erythrocyte invasion, immune evasion, and parasite virulence. Understanding the structure and function of PF14_0076 is essential for identifying its potential as a vaccine target or therapeutic intervention point. The exploration of this protein may contribute to the broader efforts to combat malaria, a disease that poses a substantial global health burden. Scientists are employing various molecular biology techniques, including gene cloning, protein expression, purification, and functional assays, to elucidate the characteristics and biological significance of PF14_0076. This research holds promise not only for understanding malaria pathogenesis but also for advancing the development of innovative strategies in malaria prevention and treatment.
